BAUSCH + LOMB CORPORATION COMMON SHARES
23.03
28-February-25 15:00:00
15 minutes delayed
Stocks
+0.17
+0.74%
Today's range
22.86 - 23.13
ISIN
N/A
Source
Toronto SE
-
Elastic (NYSE:ESTC) Shares Gap Up After Analyst Upgrade
01 Mar 2025 09:27:14 By Buzz FX
-
CompoSecure (NASDAQ:CMPO) Shares Gap Down After Insider Selling
01 Mar 2025 09:27:14 By Buzz FX
-
Nelnet (NYSE:NNI) Shares Gap Up on Better-Than-Expected Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
Global Medical REIT (NYSE:GMRE) Shares Up 4.8% After Better-Than-Expected Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
AES (NYSE:AES) Shares Gap Up After Earnings Beat
01 Mar 2025 09:27:14 By Buzz FX
-
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up After Strong Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
Ellington Financial (NYSE:EFC) Reaches New 52-Week High After Better-Than-Expected Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
Monster Beverage (NASDAQ:MNST) Shares Gap Up Following Analyst Upgrade
01 Mar 2025 09:27:14 By Buzz FX
-
Fox Factory (NASDAQ:FOXF) Shares Gap Up Following Earnings Beat
01 Mar 2025 09:27:14 By Buzz FX
-
HP (NYSE:HPQ) Stock Price Down 7.4% Following Analyst Downgrade
01 Mar 2025 09:27:14 By Buzz FX
-
Arcus Biosciences (NYSE:RCUS) Shares Gap Up Following Insider Buying Activity
01 Mar 2025 09:27:14 By Buzz FX
-
Owens & Minor (NYSE:OMI) Shares Gap Up on Strong Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap Up Following Better-Than-Expected Earnings
01 Mar 2025 09:27:14 By Buzz FX
-
Alexander & Baldwin (NYSE:ALEX) Shares Gap Up After Earnings Beat
01 Mar 2025 09:21:15 By Buzz FX
-
Need 7.3% per capita income growth for 'Viksit Bharat' by 2047: Panagariya
01 Mar 2025 09:13:22 By Buzz FX
-
Insider Buying: Tate & Lyle plc (LON:TATE) Insider Buys 20,000 Shares of Stock
01 Mar 2025 09:01:13 By Buzz FX
-
Catalyst Pharmaceuticals (NASDAQ:CPRX) Given Buy Rating at HC Wainwright
01 Mar 2025 09:01:13 By Buzz FX
-
Milestone Pharmaceuticals' (MIST) Buy Rating Reiterated at HC Wainwright
01 Mar 2025 09:01:13 By Buzz FX
-
Beam Therapeutics (NASDAQ:BEAM) Receives "Buy" Rating from HC Wainwright
01 Mar 2025 09:01:13 By Buzz FX
-
Krystal Biotech's (KRYS) "Buy" Rating Reaffirmed at HC Wainwright
01 Mar 2025 09:01:13 By Buzz FX